Article Information
PubMed
Print ISSN
Online ISSN
History
- Received January 17, 2021
- Revision received March 23, 2023
- Accepted April 3, 2023
- Published online August 14, 2023.
Article Versions
- Earlier version (April 7, 2023 - 12:18).
- You are viewing the most recent version of this article.
Copyright & Usage
U.S. Government work not protected by U.S. copyright.
Author Information
- Jürgen Wess,
- Antwi-Boasiako Oteng,
- Osvaldo Rivera-Gonzalez,
- Eugenia V. Gurevich, and
- Vsevolod V. Gurevich
- Birgitte Holst, Associate Editor
- Address correspondence to:
Jürgen Wess, Molecular Signaling Section, Laboratory of Bioorganic Chemistry, NIH-NIDDK, Bldg. 8A, Room B1A-05, 8 Center Drive MSC 0810, Bethesda, Maryland 20892. E-mail: jurgenw{at}niddk.nih.gov; or Vsevolod V. Gurevich, Vanderbilt University Medical Center, 2200 Pierce Avenue, Preston Research Building, Room 417D, Nashville, Tennessee 37232. E-mail: Vsevolod.Gurevich{at}vanderbilt.edu
Statistics from Altmetric.com
Article usage
In this issue
Jump to section
- Article
- Abstract
- I. Introduction
- II. Arrestin Structure and Function
- III. Tools for Studying Arrestin Function and Physiology
- IV. Role of β-Arrestins in Modulating Key Functions of the Central Nervous System
- V. Modulation of Cardiovascular Functions by β-Arrestins
- VI. Cancer and β-Arrestins
- VII. Regulation of Metabolic Functions by β-Arrestins
- VIII. Targeting β-Arrestins for Therapeutic Purposes
- IX. Conclusion
- Acknowledgments
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement